Reduced Variability of Endurance Time in New Protocols for Exercise Tests in COPD.


Journal

International journal of chronic obstructive pulmonary disease
ISSN: 1178-2005
Titre abrégé: Int J Chron Obstruct Pulmon Dis
Pays: New Zealand
ID NLM: 101273481

Informations de publication

Date de publication:
2020
Historique:
received: 22 06 2020
accepted: 23 09 2020
entrez: 26 11 2020
pubmed: 27 11 2020
medline: 29 6 2021
Statut: epublish

Résumé

For exercise testing of COPD patients, a standard endurance test (ET) with constant workload is recommended. The test suffers from large inter-individual variability and need for large sample sizes in order to evaluate treatment effects. A new protocol for ET in COPD was designed. In contrast to the standard ET, the new ET involved an increasing workload in order to reduce the standard deviation of endurance time. Two new ETs were compared with the standard ET. In Study A, the new ET started at 75% of the patient's maximum workload (W In Study A, that included 15 patients, the standard deviation and range for endurance time and work capacity were narrower for the new versus the standard ET. However, the higher mean workload at end and the low mean work capacity relative to the standard ET indicated that the stepwise increase was too aggressive. In Study B, that included 18 patients, with a modified protocol, the averages for endurance time, workload at end and work capacity were similar for new and standard ET, while the standard deviations and ranges for endurance time and work capacity were kept more narrow in the new ET. The variances for endurance time were not equal between the standard ET and the two new ETs (p<0.05 for both according to Levene's test). The new ET reduced the number of patients with extreme endurance times (short and long) compared to the standard test. The new test showed a significant lower variance for endurance time, which potentially can lead to fewer patients needed in comparative studies. The overall best results were observed with a low linear increase during endurance.

Identifiants

pubmed: 33239872
doi: 10.2147/COPD.S268894
pii: 268894
pmc: PMC7682444
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3003-3012

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2020 Tufvesson et al.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

Eur Respir J. 2009 Jun;33(6):1254-60
pubmed: 19483045
Respir Med. 2012 Oct;106(10):1413-20
pubmed: 22749044
Med Sci Sports Exerc. 1982;14(5):377-81
pubmed: 7154893
Respiration. 2003 Jul-Aug;70(4):367-70
pubmed: 14512671
Am J Respir Crit Care Med. 2003 Jan 15;167(2):211-77
pubmed: 12524257
Eur Respir J. 2016 Feb;47(2):429-60
pubmed: 26797036
Chest. 2005 Sep;128(3):1168-78
pubmed: 16162703
Eur Clin Respir J. 2019 Nov 20;7(1):1692645
pubmed: 31839909
PLoS One. 2011 Feb 28;6(2):e17007
pubmed: 21386991
Eur Respir J. 2009 Oct;34(4):866-74
pubmed: 19282342
Eur Respir Rev. 2019 Dec 18;28(154):
pubmed: 31852745
Am J Respir Crit Care Med. 2003 Feb 15;167(4):544-9
pubmed: 12446268
Respir Med. 2010 Oct;104(10):1450-9
pubmed: 20692140
BMC Pulm Med. 2014 May 31;14:97
pubmed: 24885117
COPD. 2014 Jun;11(3):267-76
pubmed: 24182350
Am J Respir Crit Care Med. 2006 Jun 15;173(12):1326-34
pubmed: 16543549
Eur Respir J. 2007 Jan;29(1):185-209
pubmed: 17197484
Respir Med. 2019 Oct;157:59-68
pubmed: 31522031

Auteurs

Ellen Tufvesson (E)

Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Skane University Hospital, Lund, Sweden.

Finn Radner (F)

Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Skane University Hospital, Lund, Sweden.

Georgia Papapostolou (G)

Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Skane University Hospital, Lund, Sweden.

Linnea Jarenbäck (L)

Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Skane University Hospital, Lund, Sweden.

Saga Jönsson (S)

Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Skane University Hospital, Lund, Sweden.

Ulf Nihlén (U)

Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Skane University Hospital, Lund, Sweden.

Jaro Ankerst (J)

Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Skane University Hospital, Lund, Sweden.

Alf Tunsäter (A)

Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Skane University Hospital, Lund, Sweden.

Stefan Peterson (S)

Regional Cancer Centre South, Region Skane, Lund, Sweden.

Leif Bjermer (L)

Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Skane University Hospital, Lund, Sweden.

Göran Eriksson (G)

Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Skane University Hospital, Lund, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH